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The ubiquitin ligase LIN41/TRIM71 targets p53 to
antagonize cell death and differentiation pathways
during stem cell differentiation
Duong Thi Thuy Nguyen1, Daniel Richter1, Geert Michel2, Sibylle Mitschka3, Waldemar Kolanus3, Elisa Cuevas4 and
F Gregory Wulczyn*,1
Rapidity and specificity are characteristic features of proteolysis mediated by the ubiquitin-proteasome system. Therefore, the
UPS is ideally suited for the remodeling of the embryonic stem cell proteome during the transition from pluripotent to differentiated
states and its inverse, the generation of inducible pluripotent stem cells. The Trim-NHL family member LIN41 is among the first E3
ubiquitin ligases to be linked to stem cell pluripotency and reprogramming. Initially discovered in C. elegans as a downstream
target of the let-7 miRNA, LIN41 is now recognized as a critical regulator of stem cell fates as well as the timing of neurogenesis.
Despite being indispensable for embryonic development and neural tube closure in mice, the underlying mechanisms for LIN41
function in these processes are poorly understood. To better understand the specific contributions of the E3 ligase activity for the
stem cell functions of LIN41, we characterized global changes in ubiquitin or ubiquitin-like modifications using Lin41-inducible
mouse embryonic stem cells. The tumor suppressor protein p53 was among the five most strongly affected proteins in cells
undergoing neural differentiation in response to LIN41 induction. We show that LIN41 interacts with p53, controls its abundance by
ubiquitination and antagonizes p53-dependent pro-apoptotic and pro-differentiation responses. In vivo, the lack of LIN41 is
associated with upregulation of Grhl3 and widespread caspase-3 activation, two downstream effectors of p53 with essential roles
in neural tube closure. As Lin41-deficient mice display neural tube closure defects, we conclude that LIN41 is critical for the
regulation of p53 functions in cell fate specification and survival during early brain development.
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Stem cell differentiation is driven by self-reinforcing regulatory
loops working in parallel at the transcriptional as well as
the post-transcriptional level. Less is known about
post-translational mechanisms, including possible contribu-
tions by the ubiquitin-proteasome system. The ubiquitin-
proteasome system is a major pathway for regulated protein
degradation and is known to modulate the stability and activity
of diverse factors that control cell fate decisions.1 The E3
ubiquitin ligase LIN41 was initially discovered as a critical
downstream target of the let-7 miRNA.2 Lin41 activity was
shown to be restricted to self-renewing stem cells and to
oppose the pro-differentiation role of let-7.2,3 Moreover,
reestablishment of Lin41 expression was recently shown to
be a prerequisite for the de-differentiation of somatic cells
during the generation of induced pluripotent stem cells.4
The molecular functions of LIN41 in stem cells are just
beginning to be elucidated. Also known as TRIM71, LIN41 is a
founding member of the Trim-NHL protein family.2 Unlike
C. elegans, mammalian LIN41 proteins have been shown to
possess two activities: RNA-binding and translational repres-
sion mediated by the C-terminal NHL domain4–8 and E3
ubiquitin ligase activity mediated by the N-terminal Tripartite
motif (Trim).7,9,10 The Trim domain consists of a RING-type
zinc finger, two B-Box zinc fingers and a coiled-coil domain.11
The mutational phenotypes of many of the mammalian Trim-
NHL genes cluster to the nervous system.11 Mice deficient in
Lin41 display a 100% penetrant failure of neural tube closure,
together with generalized growth retardation and embryonic
lethality.10,12–14 A role for LIN41 in neurogenesis is suggested
by defects in gene expression during neural commitment by
LIN41-deficient ES cells14 and the premature differentiation of
neural progenitors in the CNS of LIN41-deficient embryos.10
The FGF-signaling intermediate SHCBP1 was identified as a
substrate for LIN41-mediated ubiquitination in embryonic
neurogenesis.10 To better characterize the E3 ubiquitin ligase
activity of LIN41, weapplied a proteomic approach to determine
the effects of LIN41 on global ubiquitination patterns in
pluripotent ES cells and in ES cells undergoing neural
differentiation. Among a wealth of candidate substrates for
LIN41-mediated ubiquitination, the tumor suppressor protein
p53 was one of the most strongly affected proteins. Apart from
its better-known role as ‘guardian of the genome’ in response to
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stress, a number of studies have described the sensitivity
of the embryonic nervous system to perturbations in p53
regulation.15–18 In this study, we present a new node for p53
regulation by LIN41 that is specifically active during differentia-
tion of ES cells and also during embryonic neurogenesis in vivo.
We show that LIN41 interacts with p53 and promotes p53
ubiquitination. As a consequence, multiple p53-dependent pro-
apoptotic and pro-differentiation responses are reciprocally
affected by either sustained LIN41 expression in differentiating
ES cells or LIN41 deficiency in Lin41−/− ES cells or embryos.
Taken together, our results indicate that LIN41 is required to
dampen p53 responses and limit the extent of apoptosis during
neural tube closure and early brain development.
Results
LIN41 and global ubiquitination in ES cells. To identify
direct substrates for LIN41, we analyzed global ubiquitination
patterns in a previously described stable ES cell line
(iLin41 cells) that allows doxycycline (Dox)-inducible expres-
sion of LIN41.5 We used this system to manipulate LIN41
expression in two distinct cell states: (1) pluripotent cells grown
in the presence of leukemia inhibitory factor (LIF), and (2) cells
undergoing neural differentiation for 3 days in response to
retinoic acid (RA) (Figures 1a and b). Using the so-called
UbiScan method to quantify ubiquitinated peptides (Figure 1a),
we identified ~11 500 non-redundant diglycine-modified
peptides within 3549 proteins (Supplementary file 1).
In pluripotent cells, 255 proteins showed a ≥2.5-fold increase
in ubiquitination upon LIN41 induction (Supplementary file 2).
Fifty-six of these proteins were also more ubiquitinated in
response to LIN41 in differentiated cells among a total of 274
proteins (Figure 1c, Supplementary Figure 1 andSupplementary
file 3).We performed functional enrichment analysis of these two
sets of LIN41 responsive proteins to prioritize potential
candidates for LIN41-mediated ubiquitination (Figures 1d
and e). Of particular interest was the over-representation of
p53-related pathways in differentiating cells (Po0.005 = 0.002;
Figures 1e and f). In this study, we focus on regulatory
interactions between LIN41 and p53 based on their opposing
roles in regulating pluripotency and cellular reprogramming.
p53 is a potential substrate for LIN41-mediated ubiquiti-
nation. Among the LIN41 responsive proteins p53 was one
of the five most strongly affected proteins in cells undergoing
neural differentiation (Supplementary file 4). Multiple ubiqui-
tination sites were detected within the p53 protein
(Supplementary file 1). Induction of LIN41 in RA-treated cells
resulted in a three- to tenfold increase in diglycine modifica-
tion at lysines K313–315 (Figure 1g). These residues lie in a
bipartite nuclear localization sequence positioned between
the DNA binding and tetramerization domains (Figure 1g).
Ubiquitination at position K364 and K299 was also increased
more than twofold (Figure 1g). Together, these sites account
for more than 90% of all recovered p53-derived peptides
(Supplementary file 1).
Validating the effects on p53 by western blotting, we found
that induction of LIN41 in RA-treated cells led to a significant
reduction in p53 protein levels not seen in cells maintained in
LIF (Figures 2a and b). This LIN41-dependent decrease in p53
was prevented by pretreatment with the proteasome inhibitor
MG132. LIN41 induction also enhanced accumulation of
higher molecular weight signals representing modified p53 in
the presence ofMG132 (Figures 2a and c). Consistent with the
data from UbiScan, this impact of LIN41 on p53 was more
prominent in differentiated cells. p53 mRNA levels, in contrast,
did not change in response to LIN41 despite the differences
seen in protein levels (Figure 2d).
We next studied the effects of sustained Lin41 expression in
a more physiological neural differentiation paradigm that does
not require chemical inducers such as RA: Serum Free
Embryoid Body culture with quick aggregation (SFEBq).19
Similar to RA-induced differentiation, we observed a reduction
in p53 levels in response to LIN41 overexpression throughout
the early phase of neural differentiation (Figure 2e, full scan
see Supplementary Figure 4e).
LIN41 promotes ubiquitination of p53 in response to
RA. We used two approaches to characterize the LIN41-
mediated modification of p53: capture of K48 and K63 poly-
ubiquitinated proteins by tandem ubiquitin binding entities
(TUBE), and immunoprecipitation (IP) with an α-ubiquitin
antibody capable of detecting mono- as well as poly-
ubiquitinated proteins irrespective of linkage type. For
TUBE-mediated capture, we first treated all cultures with
doxorubicin to induce p53. Under these conditions, LIN41
enhanced overall p53 ubiquitination (Figure 2f). The higher
sensitivity of α-ubiquitin IP allowed us to confirm these results
without doxorubicin treatment. As in the TUBE assay, LIN41
increased the intensity of ubiquitinated p53 bands
(Figure 2g). Once again, the effect was markedly stronger
in differentiated cells, as predicted by UbiScan. As a negative
control, a poly-ubiquitination ladder detected after probing for
OCT-4 was unaffected by exogenous LIN41.
Evidence for direct physical interaction between LIN41
and p53. LIN41 localizes in the cytoplasm in ES cells,5,9
both nuclear and cytoplasmic localization have been reported
for p53.20–22 Using the monoclonal anti-p53 Pab421 antibody,
we were able to confirm partial overlap of the two proteins in
the cytoplasmic compartment (Figure 3a). We next performed
IP experiments in heterologous cells after co-transfection of
epitope-tagged LIN41 and p53. Exogenous p53 was co-
precipitated by Flag-tagged LIN41 and vice versa (Supple-
mentary Figures 2a and b). To confirm this interaction, we
next performed asymmetrical IPs in which an epitope-tagged
protein was used to immunopurify an endogenous interaction
partner. Flag-tagged LIN41 co-purified endogenous p53 and
the positive control MOV10 in HEK293 cell extracts
(Figure 3b). In reciprocal experiments, Flag-tagged p53 could
interact with endogenous LIN41 in P19 cells (Figure 3c).
Importantly, we could also demonstrate association between
the endogenous proteins in ES cells based on co-IP of LIN41
using a highly specific antibody trap for p53 (Figure 3d).
We then performed a deletion analysis to define the domain
in LIN41 responsible for p53 binding. Co-IP assays revealed
that the NHL domain of LIN41 is necessary and sufficient for
p53 binding (Figures 3e and f). To test for direct interaction, we
analyzed whether LIN41 protein synthesized in vitro would
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Figure 1 UbiScan for global identification of LIN41 ubiquitination substrates. (a) Proteomic strategy for global identification of LIN41-mediated ubiquitination targets under
self-renewal conditions (LIF) and during neural differentiation with RA using a mouse ES cell line with Dox-inducible expression of LIN41-Flag. Each extract was processed by
digestion with trypsin followed by affinity purification using an antibody specific for lysine residues carrying a diglycine linkage (K-GG). Enriched ubiquitin-modified peptides were
analyzed by spectrometry. (b) iLin41 protein extracts prepared for the UbiScan were immunoblotted with α-LIN41 and α-OCT-4 antibodies to validate LIN41 induction by Dox and
the conversion of pluripotent ES cells to differentiated cells after 3 days of RA treatment, respectively. (c) Venn diagram compares the sets of proteins showing a ≥ 2.5-fold
increase in ubiquitination after LIN41 induction between the pluripotent and differentiated cell states. (d and e) Functional annotation analysis depicting significantly enriched
Panther pathways among proteins with ≥ 2.5-fold more ubiquitination upon LIN41 induction in pluripotent (d) and differentiated (e) cells. Similar results were obtained for
enrichment of p53-related KEGG or REACTOME pathways using Gene Set Enrichment Analysis (http://software.broadinstitute.org/gsea/msigdb/index.jsp, data not shown).
(f) Diagram summarizing selected p53 pathways with LIN41 ubiquitination candidates from UbiScan depicted in blue and their functional relationships (arrow= direct activation,
dotted arrow= indirect activation, inhibition line= direct negative regulation). (g) Fold change ratio of Dox+ versus Dox− in differentiated cells for the indicated diglycine-modified
sites within p53 and schematic of p53 domain structure. DBD, DNA Binding Domain; NLS, Nuclear Localization Sequence; TAD, Transactivation Domain; TET, Tetramerization
domain. See also Supplementary Figure 1 and Supplementary files 1–4
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interact with a p53-GST fusion protein. LIN41 co-purified with
the p53-GST protein but not with either GST or MDM2-GST
(Figure 3g). Taken together, these results demonstrate that
p53 and LIN41 can interact in the absence of potential bridging
factors from ES cells.
LIN41 affects proliferation during neural differentiation.
Previous studies have shown that experimental reduction of
p53 levels in neural stem cells leads to excessive prolifera-
tion, reduced apoptosis and impaired differentiation.23,24 To
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functions, we first examined the impact of LIN41 on cell
proliferation. Induction of LIN41 increased cell numbers in
RA-treated cells but not in undifferentiated cells
(Figures 4a and b). Similar results were obtained by
measuring incorporation of BrdU as an assay for proliferation
(Supplementary Figure 3a). The effect of LIN41 on prolifera-
tion was associated with a small but significant shift
toward the S and G2 phases after 3 days of RA-induced
differentiation (Supplementary Figures 3b and c). Although
this result is consistent with cell cycle changes reported
in ES cells depleted for LIN41,5 the effect is likely too
small to fully account for the difference in cell numbers we
observed.
LIN41 induction inhibits apoptosis during ES cell
differentiation. Visual inspection of cells over the course
of differentiation suggested that the LIN41-dependent
increase in cell numbers following RA treatment might be a
consequence of greater cell viability and reduced cell death
(Supplementary Figure 4a). Therefore, we hypothesized that
the decrease in p53 levels associated with enforced LIN41
expression might protect differentiating cells from p53-
dependent cell death pathways. Using activated caspase-3
(CASP3) as a marker for apoptosis, we found that induction
of neural differentiation was associated with significant
accumulation of cleaved CASP3 (Figures 4c and d). Using
p53-deficient ES cells,22 we could show that activation of
CASP3 in response to RA stimulation is p53 dependent
(Figure 4c and Supplementary Figure 4b). Induction of LIN41
in RA-treated cells strongly inhibited CASP3 activation
(Figure 4d and Supplementary Figure 4c), without affecting
total CASP3 levels (Supplementary Figure 4f). Importantly,
this effect was not limited to RA treatment and was also seen
in two additional differentiation conditions: spontaneously
differentiating cells 3 days after LIF withdrawal as well as
SFEBq cultures (Supplementary Figures 4d and e). To
directly test whether LIN41 can antagonize pro-apoptotic
p53 function, we induced the DNA damage response in
differentiating cells with the topoisomerase II inhibitor
doxorubicin. As expected, p53 and activated CASP3 accu-
mulated strongly in response to doxorubicin in wild type but
not in p53-deficient ES cells, indicating that this apoptotic
response is dependent on p53 (Supplementary Figures 4g
and h). Importantly, LIN41 induction strongly reduced the p53
accumulation and CASP3 activation triggered by doxorubicin
in iLIN41 cells (Figure 4e).
The ability of p53 to promote cell death is based in part on
direct transcriptional activation of the pro-apoptotic factors
Puma and Noxa. Steady-state levels of Puma and Noxa
mRNA were significantly reduced upon LIN41 induction in
pluripotent cells (Figure 4f). This decrease was stronger in
differentiated cells, consistent with the stronger effect of LIN41
on p53 in these cells. The levels of Bim mRNA, a p53-
independent pro-apoptotic gene, were not affected. We then
asked if LIN41 can inhibit the transcriptional response to
doxorubicin. Stress-dependent upregulation of Puma and
Noxa mRNA levels was significantly attenuated in differen-
tiated cells upon LIN41 induction (Figure 4g). Taken together,
these results suggest that LIN41 interferes with p53-
dependent pathways that promote cell death during ES cell
differentiation.
Loss of LIN41 elevates p53 steady-state levels and
reduces p53 ubiquitination. We next determined the effect
of Lin41 deficiency on p53 in ES cells. For this purpose,
multiple independent Lin41− /− and Lin41+/− ES cell lines
were derived from knockout and heterozygote blastocysts
from Lin41-deficient mice.13 In three independent experi-
ments using three independent heterozygote and mutant
clones each we observed an increase in steady-state p53
protein levels in the knockout ES cells (Figure 5a). Despite
this increase in p53 protein, p53 mRNA levels were
unchanged (Figure 5b). Downstream of p53 we detected
significant upregulation of Noxa, but not Puma in Lin41
knockout ES cells (Figure 5c). The reason for this
selective increase of downstream effectors upon loss of
LIN41 is unclear, although there are several precedents for
uncoupling of p53 levels and transcriptional activity in
pluripotent cells.25
To further confirm the results obtained with constitutive
Lin41− /− ES cell lines, we tested p53 steady-state levels in a
Lin41fl/fl; Rosa26-CreERT2 mES cell model, which allows Cre-
mediated Lin41 disruption.14 Both acute and stable deletion of
LIN41 lead to an increase in p53 protein levels (Figure 5d).
Consistent with our overexpression system the LIN41-
dependent effect on p53 is more pronounced in cells under-
going differentiation (Figure 5e). To determine if loss of LIN41
leads to a corresponding reduction in p53 ubiquitination, we
performed TUBE and ubiquitin IP assays on Lin41fl/fl and
Figure 2 LIN41 negatively regulates p53 protein levels by ubiquitination (a) Induction of LIN41 in differentiated, but not in pluripotent, ES cells downregulates endogenous p53
protein levels (compare lane 5 with 6 and lane 7 with 8) in a proteasome-dependent manner (compare lanes 3 and 4 with lanes 7 and 8). Expression levels of p53, LIN41, OCT-4
and GAPDH were determined by immunoblotting. A short and long exposure are shown for the p53 blot. (b and c) Quantification of unmodified (b) or ubiquitin-modified (c) p53
from LIN41-induced (Dox+) relative to untreated cell extracts. Relative band intensity was quantified from immunoblots, cell treatments as in a. Data from three independent
experiments are presented as means±S.D. values. *Po0.05, **Po0.01, ***Po0.001. (d) LIN41 induction does not affect p53 transcript levels in either pluripotent or
differentiated ES cells. p53 mRNA was quantified by qRT-PCR using Oaz1 mRNA for normalization. Data from three independent experiments are presented as means± S.D.
values. (e) p53 is reduced in response to LIN41 induction during SFEBq cortical organoid differentiation. iLin41 organoid cultures were differentiated with and without Dox. p53
and LIN41 protein levels were monitored at indicated time points by immunoblotting. (f) LIN41 induction during neural differentiation promotes p53 poly-ubiquitination in vivo. Multi-
and poly-ubiquitinated proteins from pluripotent and differentiated iLin41 cells were enriched using TUBEs after p53 induction with 1 μM doxorubicin and 4 h MG132 treatment.
Ubiquitinated p53, auto-ubiquitinated LIN41 and pull-down efficiency were monitored by immunoblotting. (g) Mono- and poly-ubiquitinated proteins were purified using α-Ub-FK2-
agarose beads capable of detecting all linkage types. iLin41 cells were prepared as for TUBE assay but without p53 induction. Western blots of input lysates and eluates were
probed with a goat α-p53 antibody. Immunoblots of LIN41 and OCT-4 were included as positive and negative control, respectively. LIN41 induction increases ubiquitination levels
of endogenous p53
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Lin41− /− ES cell lysates. Using either method, LIN41 deletion
in differentiating mES cells results in a reduction of p53
ubiquitination (Figures 5f and g). Altogether, our results with
these two independent loss-of-function models further
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Figure 3 LIN41 co-localizes and physically interacts with p53. (a) iLin41 cells were immunostained for endogenous p53, LIN41 and nuclear marker Draq5. (b) Flag-tagged
LIN41 co-precipitates endogenous p53 in HEK293 cells. Co-precipitation of endogenous proteins after IP with either control IgG or α-Flag agarose was demonstrated by western
blotting. (c) Flag-tagged p53 co-purifies endogenous LIN41. P19 cells were transfected with Flag-p53 or positive control Flag-Mov10. After α-Flag-IP, LIN41 co-purified with
similar efficiency using either MOV10 or p53 as bait. (d) p53 from mouse ES cells was affinity purified using a mouse-specific p53 Trap. A human-specific p53 Trap served as
negative control. Endogenous interaction was observed between p53 and LIN41, but not with GAPDH. (e) Schematic representation of LIN41 domains and the deletion constructs
used to map the p53 interaction. (f) p53 interacts with the NHL domain of LIN41. LIN41-GFP fusion proteins containing the full-length protein or deletion constructs without the
NHL, the RING motif or with only the NHL domain were co-expressed with Flag-tagged p53 in HeLa cells. GFP was included as a negative control. Input and bound proteins after
Flag-IP were analyzed by western blotting with the indicated antibodies. (g) p53 directly interacts with LIN41. GST pull-down assays of in vitro synthesized LIN41 using GSTonly,
p53-GST fusion protein or MDM2-GST. The presence of LIN41 in bound and unbound fractions was analyzed by immunoblotting. See also Supplementary Figure 2
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Widespread apoptosis in Lin41-deficient embryos.
Deletion of LiN41 in the mouse leads to embryonic lethality
and failure of cranial neural tube closure10,12–14 (Figure 6a).
Likewise, successful neural tube closure is sensitive to
defects in p53 expression and regulation.15–17,26,27 As either
loss of Lin41 or dysregulation of p53 causes NTD, we asked
whether p53 function might be affected in Lin41 knockout
embryos. Immunostaining for p53 revealed increased nuclear
levels of p53 in the neuroepithelium of mutant embryos
compared to heterozygote littermates at E10.5 (Figures
6b and c).
Considering that LIN41 induction strongly inhibited
p53-dependent apoptosis during ES cell differentiation, we
assayed the levels of activated CASP3 in vivo. In contrast to
heterozygote embryos, Lin41− /− littermates exhibited exten-
sive cell death in the neuroepithelium and surrounding
mesenchyme (Figure 7a, Supplementary Figures 5a and b).
The increase in cell death within the Lin41-expressing
neuroepithelium was confirmed at higher magnification
(Figure 7bii, iii) and was particularly prominent in the vicinity
of the optic vesicles (Figures 7bi). These results show that loss
of LIN41 results in aberrant p53 activation and massive
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Figure 4 LIN41 affects proliferation and p53-dependent apoptosis during ES cell differentiation. (a and b) LIN41 differentially promotes proliferation in differentiating
compared to pluripotent cell states. Dox-inducible iLin41 cells were cultured under proliferative (a) or differentiation conditions (b). Cell number was determined at 24 h intervals in
triplicates. Data are presented as means±S.D. of three independent experiments. *Po0.05. (c) CASP3 activation during neural differentiation is p53 dependent. p53 WTand
p53-deficient mES cells were cultured under proliferative or differentiation conditions. Cleaved CASP3 levels were determined by immunoblotting. (d) Induction of LIN41 during
neural differentiation reduces CASP3 activation. Cleaved CASP3, p53, LIN41 and GAPDH levels of pluripotent and differentiated iLin41 cells without or with Dox treatment were
compared by immunoblotting. (e) LIN41 inhibits p53-mediated apoptosis in response to stress. iLin41 cells differentiated in the presence and absence of Dox were pulse treated
with 1 μM doxorubicin. p53 levels and CASP3 activation were determined by immunoblotting. (f) LIN41 induction in RA-differentiated stem cells reduces levels of p53 target
mRNAs. Pluripotent and differentiated populations of iLin41 cells were cultured without or with Dox. mRNA levels of direct p53 transcriptional targets (Puma and Noxa) or the non-
transcriptional target (Bim) within the apoptosis pathway were analyzed by qRT-PCR and normalized to Oaz1. Data are presented as mean values± S.D. from three independent
experiments. *Po0.05, ***Po0.001. (g) LIN41 counteracts p53’s transactivation capacity in response to stress. iLin41 cells differentiated for 3 days in the absence or presence
of Dox were pulse treated with 1 μM doxorubicin. mRNA levels of Puma, Noxa and Bim were measured by qRT-PCR assays and normalized to Oaz1. Data are presented as
mean values± S.D. from at least three independent experiments. **Po0.01, ***Po0.001. See also Supplementary Figures 3 and 4
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Figure 5 Loss of LIN41 elevates p53 steady-state levels and reduces p53 ubiquitination. (a) Comparison of p53 expression in undifferentiated wild type, heterozygote and
homozygote Lin41-mutant ES cells shows a gene dose-dependent increase of p53 protein levels in Lin41-deficient cells. (b) Lin41 deficiency in mouse ES cells does not affect
p53 transcript levels analyzed by qRT-PCR. Expression levels were normalized toOaz1mRNA. Data are presented as means±S.D. values from three independent clonal ES cell
lines per genotype. (c) Constitutive levels of the p53 effector Noxa are increased in Lin41-deficient ES cells. Expression levels of Puma, Noxa and Bim were measured by qRT-
PCR and normalized to Oaz1. Data are presented as means± S.D. values from three independent clonal ES cell lines per genotype. **Po0.01. (d) Cre-induced disruption of
LIN41 in Lin41fl/fl; Rosa26-CreERT2 mES cells upregulates p53 steady-state levels. Conditional Lin41 knockout cell lines were cultured under proliferative and differentiation
conditions. For the induction of Cre-mediated recombination, cells were treated with 500 nM 4-hydroxytamoxifen. p53, OCT-4 and LIN41 protein expression were examined in
untreated cells (lanes 1 and 5), in two independent cell lines with stable Lin41 deletion (lanes 2 and 6 plus 3 and 7) or acute loss of Lin41 (lanes 4 and 8). (e) Quantification of p53
levels in two independent lines with stable Cre-induced Lin41 deletion relative to untreated cells. Relative band intensity was quantified from immunoblots from three independent
experiments. Data are presented as means±S.D. values. *Po0.05, ***Po0.001. (f and g) Loss of LIN41 reduces p53 ubiquitination in vivo. After 4 h MG132 treatment, total
ubiquitinated proteins from 2-day RA-treated Lin41fl/fl; Rosa26-CreERT2 cells were enriched using α-Ub-FK2-agarose beads or TUBEs, as indicated. Ubiquitination levels of
endogenous p53, LIN41 and pull-down efficiency were detected by immunoblotting
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Figure 6 Increased levels of p53 during brain development in the absence of Lin41. (a) Lin41 is essential for cranial neural tube closure. Failure of neural tube closure
(asterisk) and growth retardation in Lin41− /− embryos in comparison to control Lin41+/+ littermate at E9.5 gestation. (b) Upregulated p53 expression during neural tube closure
of Lin41-deficient embryos. Transverse cranial sections of E10.5 heterozygote and homozygote knockout Lin41GT;lacZ transgenic embryos were processed for
immunohistochemistry, results for p53 and DAPI are shown. Lin41mutants display neural tube closure defects (asterisk). (c) Higher magnification of b to better visualize p53 and
LIN41 expression in the neuroepithelium. Lin41-deficient embryos exhibit increased nuclear levels of p53. In merged views, p53 is shown in green, β-galactosidase (β-Gal) from
the Lin41-gene trap allele in red and DAPI in blue
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Figure 7 LIN41 affects embryonic apoptosis and the expression of the pro-differentiation gene Grhl3. (a) Widespread apoptosis during neural tube closure of Lin41-deficient
embryos. Transverse cranial sections of E10.5 heterozygote and homozygote knockout Lin41GT;lacZ transgenic embryos were processed for immunohistochemistry, results for
activated CASP3 and DAPI are shown. Lin41 mutants display accumulation of CASP3-positive cell clusters. (b) Higher magnification of a to better visualize apoptosis in the optic
vesicle (i) and neuroepithelium (ii–iii) of Lin41-deficient embryos. In merged views, activated CASP3 is shown in red, β-galactosidase (β-Gal) from the Lin41-gene trap allele in
green and DAPI in blue. (c) Grhl3, but not Grhl2, is responsive to p53 induction in ES cells undergoing neural differentiation. qRT-PCR analysis of Grhl2 and Grhl3 mRNAs
following doxorubicin treatment. Lin41 and p53 transcript levels are unaffected, as expected. (d) LIN41 induction in RA-differentiated stem cells reduces levels of Grhl3 mRNAs.
Pluripotent and differentiated populations of iLin41 cells were cultured without or with Dox. mRNA levels of Grhl3 were analyzed by qRT-PCR and normalized to Oaz1. (e) LIN41
loss of function in mouse E9.5 embryos leads to elevated Grhl3mRNA levels.Grhl3, Lin41 and p53 transcript levels were analyzed by qRT-PCR and normalized to Oaz1. All data
are presented as mean values±S.D. from three independent experiments. *Po0.05, **Po0.01, ***Po0.001. See also Supplementary Figure 5
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programmed cell death during the period of neural tube
closure.
LIN41 modulates Grainyhead-like 3 expression. The
transcription factor Grainyhead-like 3 (GRHL3) is a p53 target
gene28 that is associated with NTDs and cell fate
specification.29–31 To determine if LIN41 affects p53
responses apart from the classical anti-apoptotic targets
Puma and Noxa, we tested Grhl3. We first confirmed that
Grhl3, but not the related Grhl2, is a strong p53 transcriptional
target in our ES cell system by treating iLin41 cells with RA for
3 days followed by induction of p53 with doxorubicin
(Figure 7c). Grhl3 levels were significantly reduced in
response to LIN41 induction specifically in differentiated cells
(Figure 7d). Conversely, Grhl3 transcript levels were elevated
in Lin41− /− embryos compared to Lin41+/+littermates, while
Lin41+/−heterozygotes displayed intermediate levels
(Figure 7e). In both the Drosophila and mouse nervous
systems, Grainyhead family transcription factors are respon-
sible for the specification and terminal differentiation of
specific stem cell populations.30,32 Therefore, by regulating
the extent of apoptosis and the cell fate determinant Grhl3,
LIN41 appears to act via two distinct but potentially
complementary processes. A schematic model summarizing
our results for LIN41 activity vis-à-vis p53 is presented in
Figure 8.
Discussion
LIN41 is a member of an emerging class of RNA-binding
proteins with E3 ubiquitin ligase activity. We report the results
of an unbiased, global screen for potential targets of the E3
ubiquitin ligase activity of LIN41 that led us to investigate the
role of LIN41 in the regulation of p53 in ES cells. Several lines
of evidence point to a connection between Trim-NHL E3
ligases and p53. The first was the finding that TRIM3 is a direct
transcriptional target of p5333 that in turn mediates degrada-
tive ubiquitination of the p53 response gene product CDKN1a/
p21.34 Like TRIM3, TRIM32 is a transcriptional target of p53
but feeds back directly by targeting p53 itself for degradative
ubiquitination.35 The first link between LIN41 and the p53
pathway was the recent finding that LIN41 mediates miRNA-
dependent post-transcriptional silencing of the Cdkn1a
mRNA, thereby limiting checkpoint control of the cell cycle in
ES cells.5
Given these precedents, we were struck by the enhance-
ment of p53-derived peptides in RA-treated cells seen in the
UbiScan. The most strongly affected sites (K313–K315) are
within the nuclear localization sequence of p53, a prominent
site for the regulation of p53 activity in ES cells.21,36
Furthermore, a knock-in mouse expressing p53 mutated for
these three residues exhibits highly penetrant developmental
abnormalities including exencephaly.37 It has proven difficult
to assign specific functions to individual lysines in p53,36
however, ubiquitination of these lysines by MDM2 has been
shown to interfere with nuclear import.38 For LIN41, our results
suggest a function in degradative poly-ubiquitination, as
indicated by the reduction in p53 protein levels in response
to ectopic LIN41 and their increase in Lin41-deficient ES cells.
However, the pattern of modified bands we see in ubiquitin
pull-down assays is also consistent with mono- and oligo-
ubiquitination. At present, we can also not exclude the
possibility that LIN41 does not act alone or directly to enhance
p53 ubiquitination. In addition to potential cooperation with
other E3 and E4 ubiquitin ligases, LIN41 might also affect
other post-translational modifications such as acetylation of
K31439 or phosphorylation of p53 by the stem cell-specific
activity of Aurora kinase A at S312.40 Alternatively, Aurora
kinase A-mediated phosphorylation adjacent to the major
ubiquitinated lysines in ES cells (K313–K315) might interfere
with p53 ubiquitination. Thus, loss of Aurora kinase A activity
after LIF withdrawal40,41 might be responsible for the
enhanced activity of LIN41 toward p53 in differentiating ES
cells. Further work will be required to more precisely define
how LIN41 fits into the network of p53 post-translational
modifications.
p53 is best known as a crucial tumor suppressor that
marshals the cellular stress response. Nevertheless, evidence
from many studies indicates that p53 regulates cell cycle exit,
metabolism and various other aspects of neural development
and differentiation in the absence of acute stress.42 Of
particular relevance, basal p53 activity was found to limit stem
cell self-renewal, as p53-deficient neural stem cells display
excess proliferation and reduced apoptosis.23,24 In our
experiments, LIN41 induction during neural differentiation
led to a modest increase in the proliferation rate and cell cycle
parameters and to a dramatic decrease in apoptosis,
mimicking the properties of p53-deficient neural stem cells.
We conclude that LIN41 acts to limit p53 activity, in particular
p53-mediated apoptosis pathways, during neural differentia-
tion of ES cells to control the balance between self-renewal,
differentiation and cell death.
Approximately 20% of female p53-deficient embryos exhibit
NTDs.17,18 More severe developmental disturbances result
from p53 hyperactivity due to loss or inactivation of negative
regulators of p53. For example, a 100% penetrant failure of
neural tube closure is observed after pharmacological
stabilization of p5315 or mutational inactivation of the MDM2-













Figure 8 Working model for the interplay of LIN41 and p53 during neural
commitment and neural tube closure. Physical interaction between LIN41 and p53
leads to ubiquitination and inactivation of p53 in cells undergoing neural
differentiation. By targeting p53, LIN41 antagonizes pro-apoptotic (CASP3) and
pro-differentiation effectors (Grhl3), two pathways downstream of p53 with essential
roles in neural tube closure. These results indicate that LIN41 is vital to dampen p53
responses and limit the extent of apoptosis in both ES cell differentiation and mouse
embryogenesis, which may account for the embryonic lethality and NTDs of Lin41-
Null mice
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dysregulation of p53 cause NTDs, suggesting that LIN41
might be essential for the regulation of p53 functions during
early brain development.
While there is some controversy regarding the importance
of apoptosis for the normal progression of neural tube closure,
excessive cell death is associated with failure of
closure.31,43,44 We found that enforced LIN41 expression
inhibited p53-dependent apoptosis during ES cell differentia-
tion and, inversely, lack of LIN41 in E10.5 Lin41− /− embryos
led to extensive cell death compared to wild type or
heterozygote littermates. Previously, Chen et al.10 reported
no significant increase in TUNEL staining of Lin41 mutant
neural tubes at E9.5 or E10.5, although they noted increased
apoptosis in the mutant hindbrain by E11.5. The activated
CASP3 antibody we used, in contrast to the TUNEL assay, can
detect cells in early phases of apoptosis and has been shown
to be approximately threefold more sensitive than the TUNEL
assay.45 Although strain-specific differences may also play a
role, we were also able to detect a differential degree of
apoptosis at E9.5, suggesting that CASP3 may be the more
sensitive assay.
Besides antagonizing p53-dependent apoptotic pathways,
LIN41 also modulates the expression of an additional p53
downstream effector, Grhl3. In the mammalian nervous
system, Grhl3 coordinates fate specification of ectodermal
progenitor cells during neurulation, a process essential for
neural tube closure.30 As a consequence,Grhl3-deficient mice
consistently display spinal closure defects associated with a
low incidence of exencephaly.29,46 Based on these convergent
functions, we suggest that misregulation of p53 and the p53
effectors we have identified account for the growth deficit,
embryonic lethality and NTDs of Lin41-deficient mice.
The reciprocal regulatory relationship between LIN41 and
let-7 is increasingly recognized as an important genetic switch
governing stem cell properties.2,4,9,14,47 However, consider-
ably more is known about downstream effectors for let-7 than
for LIN41. Despite progress in identifying substrates for the
RNA-binding activity of LIN414,5,7,8 there is a need for a better
understanding of the conserved E3 ligase activity of LIN41 and
the other Trim-NHL family members. In this study, we address
this need and describe a new layer of post-translational stem
cell regulation by LIN41: the ubiquitination and inhibition of the
pro-differentiation and pro-apoptotic activities of p53. We
suggest that one vital role of LIN41 is to restrain p53 activity to
favor cell differentiation over cell death.
Materials and Methods
Plasmids. GFP-hAgo2 #11590, pFLAG/HA-Mov10 #10976, pcDNA3 flag p53
#10838, GFP-p53 #12091 and pFRT/FLAG/HA-DEST Eif2c2 #19888 used for
transfection were purchased from Addgene Inc., Cambridge, MA, USA). peGFP-C1
(Clontech) and p3xFLAG-CMV-10 were transfected as negative controls for co-IP
assays. Generation of p3xFLAG-Lin41 and Lin41-eGFP deletion mutant series were
described in Rybak et al.9 For cloning of the T7-Lin41 construct, full-length Lin41
was amplified from the p3xFLAG-Lin41 vector using the NdeI-p3xFlag-CMV-10 F
and C-CMV-24 Sequencing primer (for primer sequences, see Supplementary
Table 1). The PCR fragment was digested by NdeI and BamHI enzymes and
inserted in the DHFR control plasmid after removing the DHFR gene.
Mammalian cell culture and transfection. HEK293T (Human Embryo-
nic Kidney) and HeLa (Human Cervix Carcinoma) cells purchased from the German
Collection of Microorganisms and Cell Cultures (Braunschweig, Germany) were
grown as adherent monolayers in DMEM supplemented with 10% fetal bovine
serum (FBS), 2 mM glutamine, 50 U/ml penicillin and 50 μg/ml streptomycin at 37 °
C in a humidified incubator with 5% CO2. Plasmid transfection of HEK293T and
HeLa cells was performed with calcium phosphate. Cells were seeded in a 10 cm
culture dish 1 day before transfection to attain 90% confluence. Medium was
replaced 2–4 h prior to transfection. A measure of 500 μl calcium–DNA solution,
containing 30 μg plasmid DNA, 62.5 μl 2 M CaCl2 and MilliQ water, was added
dropwise to an equal volume of 2 × HBS phosphate solution (280 mM NaCl,
1.5 mM Na2HPO4, 50 mM HEPES pH 7.13) with continuous vortexing. After a 30-
min incubation at room temperature the precipitate was distributed dropwise over
the cells under gentle agitation of the culture plate. Cells were incubated overnight
under standard growth conditions before collecting for IP assays.
P19 embryonic carcinoma cells were maintained in α-MEM with 10% FBS,
50 U/ml penicillin and 50 μg/ml streptomycin. Cells were transfected with
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). Six hours prior to transfection
8 × 105 cells were seeded per well of a six-well plate in 2 ml Opti-MEM (Invitrogen)
and 3% FBS without antibiotics. For each transfection 5 μl Lipofectamine was diluted
in 150 μl of Opti-MEM without serum. In a second reaction tube, 2 μg DNA was
diluted in the same volume of Opti-MEM. Subsequently, DNA and Lipofectamine
solutions were mixed and kept for 20 min at room temperature allowing formation of
liposome complexes before adding dropwise to the cells. After 16 h incubation under
standard growth conditions, the DNA–lipid complexes were removed by changing to
P19 complete growth medium. Cells were collected for further analysis 48 h post
transfection.
ES cell culture and differentiation. Dox-inducible Flag-Trim71 KH2 ESC
lines (iLin41) were a gift from Dr Richard Gregory.5 Induction of LIN41 expression
was obtained by addition of 0.5 μg/ml Dox. This allows binding of the tetracycline-
controlled transactivator rtTA to the tet operator and thus induces LIN41-Flag
expression. The iLin41 mouse embryonic stem cell line was cultured under feeder
free conditions on 0.2% gelatin-coated plates in DMEM (Gibco #21969-035,
Carlsbad, CA, USA), supplemented with 20% FBS (PANSera, 2602-P272405,
Pan-Biotech, Aidenbach, Germany), 1% L-glutamine, 20 mM HEPES
(Gibco #15630114), 1 × MEM NEAA (Gibco #11140), 1% Pen/Strep, 0.1 mM β-
mercaptoethanol (Gibco #31350) and 1000 U/ml LIF (#GSR-7001 MTI-GlobalStem,
Gaithersburg, MD, USA) (ES cell medium). For general maintenance, iLin41 cells
were grown to 70–80% confluency and passaged every 2 days at a ratio of 1 : 8.
To perform experiments with iLin41 cells under proliferative conditions, 7 × 105
cells were seeded on a 6 cm culture dish and cultured for 48 h in ES cell media
containing LIF. For spontaneous differentiation by LIF removal, 105 cells were seeded
on a 6 cm dish in ES cell medium. Eighteen hours later cells were washed once in ES
cell medium without LIF and cultured for 72 h in ES cell medium without LIF. For
neural differentiation using RA, 18 h after seeding (1.5 × 105 cells/6 cm) in ES cell
medium, medium was replaced with ES cell medium without LIF supplemented with
5 μM RA and was replaced every 2 days. Cells reached 90% confluence after 3 days
of RA treatment and were collected for further analysis.
The protocol for SFEBq19,48 was used to induce cortical differentiation in iLin41 ES
cells in the absence or presence of 2 μg/ml Dox. On Day 0, iLin41 cells were
dissociated to a single-cell suspension in 0.25% (wt/vol) trypsin-EDTA and seeded
(3000 cells in 100 μl/well) in cortical differentiation medium (GMEM from Gibco
#11710-035, 1% MEM NEAA, 1% pen/strep, 1 mM sodium pyruvate, 10% knockout
serum replacement from Invitrogen #10828028, 0.1 mM β-mercaptoethanol) in 96-
well Lipidure-Coat U-bottom low-cell-adhesion plates (Amsbio #AMS.51011610,
Abingdon, UK). After 2 days of differentiation and on consecutive days thereafter to
Day 7, the resulting spheroid cell aggregates were collected for immunoblot analysis.
For this purpose, eight aggregates per condition were transferred to PBS. After
removing PBS, settled aggregates were lysed in 100 μl lysis buffer (100 mM Tris pH
6.8, 1% SDS, 25 mM EDTA, 25 mM EGTA, 1 × protease inhibitor cocktail) and
sonicated using a Bioruptor for 10 cycles of 30 s on/30 s off at high intensity. A
measure of 33 μl of 4 × SDS loading buffer was added directly to the lysate and
heated at 95 °C for 5 min. An amount of 10 μg protein of the crude lysate was
resolved by SDS-PAGE, followed by western blotting.
Multiple-independent Lin41− /− and Lin41+/− ES cell lines from knockout and
heterozygote blastocysts from a mouse strain in which Lin41 is inactivated by a gene-
trap insertion in the second intron13 were generated using standard procedures.
Details are available upon request. These stem cell lines were generally maintained
on a layer of feeder cells on 0.2% gelatin-coated plates in Advanced DMEM/F12
(Invitrogen #12634010) supplemented with 20% knockout serum replacer, 2 mM
L-glutamine, 1% pen/strep, 0.1 mM β-mercaptoethanol and 1000 U/ml LIF. One day
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before seeding, 6 cm dishes were coated with 1 ml sterile-filtered 0.2% gelatin
solution in PBS for at least 30 min and incubated at 37 °C. Mitomycin-C-treated CF1
MEF feeder cells (CellSystems ASF-1223) were seeded at a density of 2 × 105 cells
per 6 cm dish in DMEM supplemented with 10% FBS, 2 mM glutamine, 1% pen/strep
and grown overnight. The next day, 3.5 × 105 cells were seeded on the prepared MEF
dishes, and medium was changed to ES cell medium with LIF. ES cells were split
every second day for maintenance or collected 48 h after seeding.
The conditional Lin41 knockout mES cell line (Lin41fl/fl; Rosa26-CreERT2)14 was
cultured under feeder free conditions on gelatin-coated plates in Knockout DMEM
(Gibco #10829018) supplemented with 15% FCS, 1% MEM NEAA, 1 × Glutamax,
1% pen/strep, 0.1 mM β-mercaptoethanol and LIF. For stable Lin41 deletion, the Cre
recombinase was induced using 500 nM 4-hydroxytamoxifen (Sigma, St. Louis, MO,
USA) for 48 h. Cells were further cultured for at least five passages before use in
experiments. Differentiation experiments were performed as described for
iLin41 cells.
p53-deficient and parental mES cell lines were a gift from Dr Hitoshi Niwa.22 These
cells were cultured without feeder cells on gelatin-coated dishes in Glasgow minimal
essential medium (Gibco # 11710035) supplemented with 10% FBS, 1 mM sodium
pyruvate, 0.1 mM β-mercaptoethanol, 1 × MEM NEA, 1% pen/strep and LIF.
Ubiscan and bioinformatic analysis. For the global screen of LIN41’s
ubiquitination targets, a set of four extracts was prepared from Dox-inducible Flag-
Trim71 KH2 mouse ES cells (iLin41)5 cultured in the presence or absence of Dox
and maintained either 48 h in the pluripotent state in the presence of LIF or
subjected to RA-induced differentiation for 3 days. Prior to cell lysis, cells were
treated with 20 μM MG132 for 4 h. After two wash steps with 10 ml ice-cold PBS,
cells were lysed by scraping in 10 ml urea lysis buffer (20 mM HEPES pH 8, 9 M
Urea, 1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate, 1 mM
β-glycerophosphate). These lysates were further processed and analyzed for
global ubiquitination profiling by Cell Signaling (UbiScan, Cell Signaling). For this
purpose, equal amounts of protein extract were reduced with 4.5 mM DTT and
alkylated with 10% iodoacetamide. After tryptic digestion with 10 μg/ml trypsin-
TPCK (Promega, Madison, WI, USA) peptides were separated from non-peptide
material by C18 solid-phase extraction prior to lyophilization. Peptides were affinity
purified using an agarose-conjugated antibody specific for lysine residues carrying a
diglycine linkage (K-GG) (Cell Signaling #8925). To desalt and concentrate the
eluate, peptides were loaded onto a 10 cm × 75 μm PicoFrit capillary column
packed with Magic C18 AQ reversed-phase resin. The column was developed with
a 120-min linear gradient of acetonitrile in 0.125% formic acid delivered at 280 nl/
min. Tandem mass spectra were collected with an LC-MS/MS analysis using LTQ-
Orbitrap-Elite, ESI-CID (MS parameter settings: MS run time 120 min, MS1 scan
range (300.0–1500.00), top 20 MS/MS (min signal 500, isolation width 2.0,
normalized coll. energy 35.0, activation-Q 0.250, activation time 20.0, lock mass
371.101237, charge state rejection enabled, charge state 1+ rejected, dynamic
exclusion enabled, repeat count 1, repeat duration 35.0, exclusion list size 500,
exclusion duration 40.0, exclusion mass width relative to mass, exclusion mass
width 10 ppm). MS/MS spectra were evaluated using SEQUEST 3G and the
SORCERER 2 platform from Sage-N Research (v4.0, Milpitas CA).49 Searches
were performed against the NCBI Mus musculus database, release date 28 June
2011, with mass accuracy of +/− 50 ppm for precursor ions and 1 Da for product
ions. Results were filtered with mass accuracy of +/–5 ppm on precursor ions and
presence of the intended motif. The default false positive rate was set at 5%. The
full results of the four samples analyzed in duplicates are provided in
Supplementary file 1. The functional annotation tool of the database for annotation,
visualization and integrated discovery v6.750 was used to identify significantly
enriched Panther pathways (P≤ 0.05) among peptides with more than 2.5-fold
ubiquitination.51 To prioritize potential candidates with highest ubiquitin modification
upon LIN41 induction (Supplementary file 4), we increase confidence by filtering the
PTMScan data based on fold change ≥ 2.5, max intensity 4200 000 and CV
o50%.
Western blots. Protein lysates were generally prepared from cells grown as
monolayers. For urea lysates, cells were directly scraped in urea lysis buffer at room
temperature. After 15 min incubation on ice, protein lysates were clarified by
centrifugation at 12 000 × g, 4 °C for 15 min. Total protein concentration of crude
lysates was routinely determined using Bradford assay (Bio-Rad Protein Assay,
Hercules, CA, USA) with bovine albumin serum as calibration standard (0-1 μg/μl)
at 595 nm wavelength in the photometer (Nanodrop). The separation of proteins
was achieved in 6–15% polyacrylamide gels using the Bio-Rad SDS gel
electrophoresis system. Subsequently, proteins were transferred to an ImmobilonP
membrane (Millipore, Billerica, MA, USA) and incubated in blocking buffer (5% non-
fat dry milk or 3% BSA in 1 × PBS-T). Dilutions of primary antibodies used are
provided in Supplementary Table 2, incubation time was adjusted as required. After
washing, horseradish peroxidase-conjugated secondary antibodies were applied
for 1 h. Chemiluminescent detection was performed using ECL substrate
Bio-Rad Clarity and the imaging system ImageQuant LAS (GE Healthcare, Little
Chalfont, UK).
Ubiquitination assay. For in vivo ubiquitination assays, 4.5 × 106 iLin41 cells
were grown on a 25 cm culture dish for 48 h in ES cell medium containing LIF as
pluripotent stem cells. For differentiated cells, iLin41 cells were seeded 1 day before
neural differentiation (1.2 × 106 per 25 cm plate) in ES cell medium and cultured
72 h in RA-containing medium. Prior to cell lysis, cells were pulse treated for 1 h
with 1 μM doxorubicin to increase p53 protein levels. Subsequently, fresh medium
with 20 μM proteasome inhibitor MG132 was added for 4 h to stabilize ubiquitinated
proteins. Cells were washed with 10 ml PBS and collected directly by scraping in
1.5 ml TUBE lysis buffer (50 mM Tris-HCl pH 7.5, 0.15 M NaCl, 1 mM EDTA pH 8,
1% NP-40, 10% glycerol, 50 mM chloroacetamide, 50 mM NaF, 5 mM Na4P2O7,
10 mM β-glyceropyrophosphate, 20 μM MG132, 1 × protease inhibitor cocktail).
Lysates were incubated 10 min on ice and clarified by centrifugation for 15 min at
14 000 × g. A measure of 30 μl of the homogenate was taken for the examination of
the input by western blot. Subsequently, the lysates were precleared by incubation
with 30 μl of 50% protein A/G beads slurry (Thermo Scientific, Waltham, MA, USA)
for 30 min at 4 °C in a tube rotator. Precleared cell lysates were tumbled end-over-
end overnight at 4 °C with 30 μl equilibrated TUBE-agarose 2 (Life Sensors,
Malvern, PA, USA) beads. These affinity ubiquitin traps bind preferentially to
proteins modified by K63 and K48 poly-ubiquitinated linkages. After IP, the resin was
collected by low-speed centrifugation (1500 × g, 4 °C) for 5 min. Bound complexes
were washed four times with TBS-T buffer and eluted with one bead volume of 2 ×
SDS reducing sample buffer by boiling for 5 min at 98 °C. The samples were
centrifuged for 1 min at 13 000 × g at 4 °C. Supernatants were resolved by 10%
SDS-PAGE, followed by immunoblotting with α-ubiquitin and substrate-specific
antibodies.
As a second test for in vivo ubiquitination, we used a highly efficient α-multi-
ubiquitin monoclonal antibody (clone FK2, MBL) covalently coupled to agarose
beads. This antibody detects all linkage types of mono- and poly-ubiquitinated
proteins. iLin41 cells were prepared as for the TUBE assay but without p53 induction.
An amount of 2.5 mg total protein was added to 25 μl FK2 ubiquitin resin and tumbled
overnight at 4 °C. After washing with TUBE buffer (all centrifugation steps were
performed at 2500 × g for 10 s at 4 °C), bound proteins were eluted and analyzed by
immunoblotting.
Ubiquitin assays with 2 days RA-stimulated Lin41fl/fl; Rosa26-CreERT2 cells were
performed as described for iLin41 cells but without p53 induction.
Immunoprecipitation. α-Flag IPs to determine protein–protein interaction
partners were performed from extracts of HEK293T, HeLa or P19 cells transiently
expressing Flag-fusion constructs (p3XFLAG-Lin41, Flag-p53, pFLAG/HA-Mov10,
pFRT/FLAG/HA-DEST Eif2c2, p3XFLAG-CMV-10). Cleared cell lysates of 90–95%
confluent 10 cm diameter tissue culture plates were prepared in 200 μl non-
denaturating co-IP buffer (2% Triton X, 1 × protease inhibitor cocktail in 1 × PBS,
pH 7.4). A measure of 20 μl of the homogenate was taken for examination of the
input by western blot. IP was carried out with the rest of the lysate. For that
purpose, the volume of the protein suspension was brought to at least 500 μl with
Co-IP buffer. Subsequently, the lysate was precleared by incubation with 30 μl of
50% protein A/G beads slurry (Thermo Scientific) for 1 h at 4 °C in a tube rotator.
Precleared cell lysates were tumbled end-over-end overnight at 4 °C with 30 μl of
α-Flag M2 agarose (Sigma). The immune complex was collected by centrifugation
for 10 s at 10 000 × g, 4 °C and washed at least five times with ice-cold Co-IP buffer.
Next, the beads were washed once more with 1 ml ice-cold PBS and the mixture
was transferred in a new 1.5 ml tube before centrifugation. After removing the
supernatant completely, 30 μl of 2 × SDS-PAGE loading buffer was added to the
15 μl of settled beads containing bound antigen. For elution, samples were then
heated for 5 min at 95 °C, spun down and 25 μl/lane analyzed by western blotting.
Endogenous precipitation. For each endogenous IP 1.8 × 106 uninduced
iLin41 mouse embryonic stem cells were cultured for 48 h in ES cell medium
containing LIF in a 10 cm dish. After washing with PBS, cells were collected by
scraping in 1 ml PBS and recovered by centrifugation at 6000 × g for 5 min at 4 °C.
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The cell pellet was resuspended in 200 μl ice-cold lysis buffer (1% Triton X-100, 1 ×
protease inhibitor cocktail in 1 × PBS) by passing five times through a 25-G syringe.
After a 30-min incubation on ice, the lysate was cleared for 15 min at 13 000 × g at
4 °C. Ten percent of the homogenate was taken for the examination of the input. For
the IP, the rest of the lysate was diluted with 300 μl STE buffer (10 mM Tris-HCl pH
7.5, 150 mM NaCl, 1 mM EDTA pH 8, 1 × protease inhibitor cocktail). Subsequently,
25 μl of equilibrated p53 Trap_A (Chromotek, Martinsried, Germany) bead slurry
was added per reaction and incubated for 1 h at 4 °C. p53 C-term-Trap_A reacts
with both human and mouse p53, whereas p53 N-term Trap_A only detects human
p53 and therefore served as a control for unspecific binding. Beads were recovered
by centrifugation at 2500 × g for 2 min at 4 °C, washed three times with STE buffer
and resuspended in 30 μl 2 × SDS sample buffer for elution by boiling.
In vitro Protein synthesis. LIN41 protein for the in vitro interaction assays
was generated using the PURExpress In Vitro Protein Synthesis Kit (New England
Biolabs, Ipswich, MA, USA). For creating a Lin41 template containing the T7
promoter, ribosome-binding site and T7 terminator required for a one-step
transcription and translation, the DHFR gene from the positive control plasmid of the
kit was replaced with Flag-tagged full-length Lin41 cDNA. To remove residual
RNaseA activity from plasmid DNA preparation, ethanol precipitation was carried
out. An amount of 500 ng of the purified DNA in 10 mM Tris-HCl pH 8 was added to
the in vitro expression reaction containing 10 μl solution A, 7.5 μl solution B, 20
units RNase inhibitor, ad 25 μl with nuclease-free H2O. After 3 h at 37 °C 25 μl
glycerol was added to the reaction. A measure of 5 μl of the sample was loaded on
a SDS gel to estimate the protein concentration by Coomassie staining with
PAGEblue.
GST pull-down. For examination of direct protein interactions in vitro, GST pull-
down assays were performed. A measure of 50 μl of glutathione-sepharose 4B
beads (GE Healthcare) were equilibrated with GST buffer (50 mM NaCl, 50 mM
Tris-HCl pH 7.5, 5 mM EDTA, 1% Triton X-100 and 1 × protease inhibitor cocktail).
An amount of 1 μg GST (Sigma #SRP5348), 6 μg p53-GST (Enzo #BML-FW9370-
0050) or MDM2-GST (Enzo #BML-UW0200-0025) was added to the beads in
800 μl GST buffer and incubated on a rotator for 1 h at 4 °C. The resin was then
collected by low-speed centrifugation (500 × g for 20 s at 4 °C), washed once with
500 μl of complete GST buffer and twice with GST buffer without protease inhibitor
cocktail. A measure of 10 μl of in vitro synthesized LIN41 protein were added to the
GST-coupled matrix and tumbled end-to-end in 800 μl GST buffer for 2.5 h. After
centrifugation, 30 μl of the supernatant was saved as unbound fraction for western
blot analysis. The immunoprecipitates were washed three times with GST buffer
without protease inhibitor cocktail, resuspended in one bead volume of 2 × SDS
sample buffer and heated at 95 °C to release bound proteins for subsequent
analysis by immunoblotting.
Quantitative real-time PCR. Total RNA was isolated from cell lines using
TRIZOL reagent (Ambion, #15596026, Carlsbad, CA, USA) in accordance with the
manufacturer’s instructions. RNA concentrations were measured using NanoDrop.
An amount of 2 μg of total RNA was subjected to DNase treatment using two units
of the RQ1 RNase-free DNase (Promega #M6101) for 30 min at 37 °C.
Subsequently, cDNA was synthesized using the RevertAid Premium Reverse
Transcriptase (Thermo Scientific) kit and oligo(dT) primer. cDNA was diluted 1 : 3
before analysis by qRT-PCR. Small quantities of RNA were extracted and purified
using the miRNeasy Micro Kit (Qiagen, Hilden, Germany) according to the
manufacturer’s instructions. Residual amounts of DNA were removed by on-column
DNase digestion. An amount of 500 ng RNA was transcribed into cDNA. Gene
expression was quantified by Maxima SYBR Green/Rox qPCR (Thermo Scientific
#K0223) performed on a StepOnePlus Real-Time PCR system (Applied
Biosystems). Oaz1 and β-Actin as housekeeping genes were used for normalization
of loaded cDNA. Gene-specific primers were ordered from Metabion and are listed
in Supplementary Table 1.
Immunofluorescence microscopy. For co-localization assays, 105
iLin41 cells were seeded as a monolayer 24 h before processing for immuno-
cytochemistry. Cells were washed twice with ice-cold PBS and fixed with 4% PFA for
10 min at 4 °C. After further washing with PBS, blocking of unspecific binding was
performed in 10% FBS, 0.2% gelatin, 0.25% Triton X, 1% BSA in 1 × PBS for 2 h at
room temperature. Cells were stained with primary antibodies diluted in blocking
solution overnight at 4 °C (see Supplementary Table 2). After washing cells were
incubated with 1:500 diluted secondary antibody and optional Draq5 (1:2000) for
1-2 h at room temperature. Alternatively, nuclei were visualized by staining with
DAPI during the final washing steps. Finally, the cover slips were mounted to glass
slides and co-localization was analyzed using a Leica SL or SP8 confocal
microscope.
For preparation of cryo-sections, E9.5 or E10.5 embryos were isolated and fixed in
4% (w/v) paraformaldehyde in PBS overnight and cryo-protected with a 10–20–30%
sucrose PBS gradient. On the day of embedding, embryos were incubated in a 30%
sucrose/7.5% gelatine solution at 37 °C until sinking. The bottom of the plastic
embedding mold was covered with the sucrose/gelatine solution and incubated at
4 °C for 1 h. On top of this solidified layer, the embryo was then placed in the desired
orientation according the sectioning surface and covered avoiding bubbles using the
37 °C pre-warmed gelatin/sucrose solution. In order to quickly freeze the embedding
medium, the mold was placed onto a slurry of dry-ice in 2-methylbutane. Before cryo-
sectioning, the tissues were stored at − 80 °C. Cryo-sections at 12 μm thickness
were cut using a Microm HM5000 M cryostat, mounted onto superfrost slides, dried
for 1 h at room temperature and stored at − 80 °C until use. For immunohistoche-
mistry, frozen slices were thawed at room temperature, profiled with a hydrophobic
pen (DAKOpen) and washed with PBS for 20 min under soft shaking. Then sections
were pre-incubated with blocking solution (0.25% Triton X, 3% BSA in 1 × PBS) at
room temperature for 1 h and incubated with 100 μl primary antibody (for
concentration, see Supplementary Table 2) diluted in blocking buffer in a humid
chamber at 4 °C overnight. After three 20 min-washing steps with PBS, slices were
stained with fluorescence-conjugated secondary antibody protected from light for 2 h.
The sections were further washed three times with PBS including DAPI staining in the
last washing step. Finally, the sections were mounted with fluorescent-protective
mounting media until set. Images were taken using an Olympus BX51
epifluorescence microscope or SP8 confocal microscope and processed with
Photoshop or ImageJ.
Cell number and proliferation assay. To compare the proliferation of
control and LIN41-induced ES cells, the cell number was monitored over time. Initial
seeding was 6.7 × 104 cells per 24-well for pluripotent conditions and 1.3 × 104 cells
per 24-well for cells treated with RA. In 24 h intervals, cells were trypsinized for
manual counting. Each time point was analyzed in triplicates. Three independent
experiments were performed for the statistical analysis.
The Cell Proliferation ELISA Kit (Roche) for colorimetric quantification was used
according to the manufacturer’s protocol. Initial seeding was 1 × 104 cells for
pluripotent conditions and 2 × 103 cells for cells treated with RA per flat-bottom
96-well. Cells were cultured with or without Dox as appropriate in a final volume of
100 μl. BrdU incorporation was measured using a Varioskan Flash spectral
scanning multimode reader (Thermo Scientific) at 370 nm. Each time point was
analyzed in triplicate. Three independent experiments were performed for the
statistical analysis.
Cell cycle analysis. Cell cycle stages were analyzed under differentiation
conditions by staining with propidium iodide (PI).52 A total of 4.8 × 105 cells were
seeded per 10 cm dish. After 72 h of RA-induced differentiation, cells were
trypsinized. Single-cell suspensions with 2 × 106 cells for each sample were
prepared in 0.5 ml ice-cold PBS. For fixing, 4.5 ml cold 70% ethanol was added and
samples were incubated for at least 2 h at 4 °C. Cells were pelleted by
centrifugation for 5 min at 300 × g and washed with 5 ml PBS. After a further
centrifugation step at 1000 × g for 5 min, the pellet was resuspended in 1 ml PI
staining buffer (0.1% Triton X-100, 100 μg/ml DNase-free RNase A in PBS). Half of
this cell suspension served as PI-negative control. The other half of the sample was
stained for 30 min with 10 μg/ml PI (Life Technologies #P3566, Carlsbad, CA, USA)
at room temperature in the dark before cell fluorescence of 20 000 events was
measured by flow cytometry (BD Canto II). Prior gating for live cells, single cells
were gated using width and area parameters of PI. An area parameter histogram
was plotted using FlowJo10 software to define percentage of cells in G1, S and G2/
M phases.
Statistical analysis. Data collected from at least three independent
experiments are presented as mean± S.D. Statistical testing was performed using
GraphPad Prism 5. Multi-group comparisons were analyzed by two-way ANOVA
with the Bonferroni post-test (Figures 4a, b and Supplementary Figures 3a–c).
Statistical differences between two groups were determined by a Student’s t-test.
When comparing selected groups with one independent variable one-way ANOVA
analysis with Bonferroni’s multiple comparison test was employed. Significance is
denoted in the figures as: ***Po0.001; **Po0.01; *Po0.05.
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Animal use. All mice experiments were performed according to the applicable
European and German laws, following the Animal Welfare Act and the European
legislative Directive 86/609/EEC and approved by the Animal Welfare Committee of
the Charité, Berlin.
Heterozygote Lin41+/gt mice13 were mated overnight and a positive copulation
plug was considered as embryonic Day 0.5 (E0.5). At E9.5 and E10.5, anesthetized
mothers were killed by cervical dislocation. Both uterine horns containing embryos
were removed and washed in sterile PBS on ice. Each embryo was dissected
from the decidua with the yolk sac and amnion and then either immediately fixed in
4% PFA overnight for immunohistochemistry or flash-frozen in liquid nitrogen for RNA
and protein extraction. For genotyping, genomic DNA was extracted from the
yolk sac by lysis in 100 μl DirectPCR Lyse Reagent Tail (Peqlab 31-101-T) and
0.3 mg/ml Proteinase K for 30 min at 55 °C. Subsequently, Proteinase K was
inactivated by heating for 45 min at 85 °C. After centrifugation for 10 s at
maximum speed to pellet tissue debris, 1 μl of the supernatant was subjected to
genotyping. PCR was performed using Go-Taq DNA polymerase kit (Promega
#M3008) and three primers (Exon 2 F, Exon 2 R and GT R) to discriminate between
the wild type (457 bp) and gene trap (600 bp) allele (for primer sequence, see
Supplementary Table 1).
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